Journals
Books
Articles by keyword ингибитор
FUNCTIONAL STUDY OF THE NEW SYNTHETIC THROMBIN INHIBITOR HC-019S-IOC IN VITRO AND ITS TRIAL IN VIVO AS A PART OF A PLASMA SUBSTITUTING SOLUTION IN MODEL OF HEMODILUTION IN RATS
E.I. Sinauridze, S.S. Surov, I.V. Gribkova, A.S. Gorbatenko, M.Y. Monakov, F.I. Ataullakhanov
Matrix metalloproteinases and clinico-morphological characteristic of ovarian neoplasms
N.E. Kushlinsky, E.S. Gershtein, N.V. Levkina, D.N. Kushlinsky, I.V. Tereshkina, K.P. Laktionov K.P., L.V. Adamiyan
The System of Control for Protection Against Hydrates in Gas-Transport System
V.V. Buc
NEW DIRECT LOW MOLECULAR WEIGHT SYNTHETIC THROMBIN INHIBITORS
E.I. Sinauridze, A.N. Romanov, O.A. Kondakova, I.V. Gribkova, S.S. Surov, A.S. Gorbatenko, Y.V. Kuznetsov, A.A. Bogolyubov, V.B. Sulimov, F.I. Ataullakhanov
Interaction Photoraised Oxifenil Radicals with Ions of Cobalt and Iron
V.I. Porhun, V.A. Navrotskii, L.N. Rygalov
DIRECT ELECTROMETRIC DEFINITION OF EFFICIENCY CORROSION INHIBITORS USING THE PROCESSES OF STEADY-STATE DIFFUSION
V.V. Leonov, M.Yu. Dolomatov, V.V. Ragulin, A.A. Daminov
Endothelin-converting enzyme inhibitor promotes renovascular hypertension development in rats (1 kidney-1 clip Goldblatt model)
M.E. Ilatovskaya, S.I. Sofronova, V.F. Pozdnev, N.A. Medvedeva
Clinical Prospects of Matrix Metalloproteinases and Their Tissue Inhibitors Study in Ovarian Cancer Patients
E.S. Gershtein, N.V. Levkina, I.V. Tereshkina, V.D. Ermilova, N.D. Kushlinskii, Yu.V. Kruk, O.M. Kuznetsova, L.V. Adamyan, K.P. Laktionov
Matrix Metalloproteinases in Ovarian Cancer Patients
E.S. Gershtein, N.V. Levkina, I.V. Tereshkina, V.D. Ermilova, D.N. Kushlinsky, V.B. Nosov, L.V. Adamian, K.P. Laktionov
Prognostic significance of urokinase and tissue type plasminogen activators and their type 1 inhibitor in the tumors of colorectal cancer oatients: results of 10 years follow-up
E.S. Gershtein, V.V. Prorokov, N.E. Kushlinsky
Clinical Prospects of Matrix Metalloproteinases 2, 7, 9 and Their Tissue Inhibitors Study in Colorectal Cancer Patients
E.A. Korotkova, E.S. Gershtein, V.V. Prorokov
Perspectives in creating anticancer drugs against urokinase-type plasminogen activator system
I.B. Beloglazova, Zh.A. Akopyan, M.N. Karagyaur, O.S. Plekhanova, E.V. Syomina, D.V. Stambolsky
Comparative elisa study of metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors and plasma of gastric cancer
E.S. Gershtein, I.S. Stilidi, N.E. Kushlinskii, M.I. Davidov
Medicinal plants as the sources of natural «quorum sensing» inhibitors
D.G. Deryabin - Dr.Sc. (Med.), Professor, Head of the Microbiological Department, Orenburg State University. E-mail: dgderyabin@yandex.ru
A.A. Tolmacheva - Post-graduate Student, Microbiological Department, Orenburg State University. E-mail: annatolmacheva56@gmail.com
Inhibitors of DNA repair enzymes as prototypes of medicinal preparations
A.L. Zakharenko -Ph.D.(Chem.), Research Scientist, Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (Novosibirsk). E-mail: sashaz@niboch.nsc.ru N.I. Rechkunova - Ph.D.(Chem.), Senior Research Scientist, Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (Novosibirsk); Associate Professor, Novosibirsk State University (Novosibirsk). E-mail: nadyarec@niboch.nsc.ru O.I. Lavrik - Dr.Sc.(Chem.), Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (Novosibirsk); Professor, Novosibirsk State University (Novosibirsk). E-mail: lavrik@niboch.nsc.ru
Gender differences in efficacy therapy of old and senile patients with hypertentisive disease stage III of and fluence weather factors
R.M. Zaslavskaya - Dr.Sc.(Med.), Professor, Main Specialist, Institute of Cosmic Investigation RAN (Moscow). Е- mail: rinazaslavskaya@mail.ru L.V. Krivcikova - Physician Cardiologist, GBUZ MKNZ DZM (Moscow). Е- mail: lkrivchikova@bk.ru M.M. Tejblum - Ph.D. (Biol.), Director Substitute, Information Department of Medical « Solidarity for life» (Moscow). Е- mail: misha@tejblum.pp.ru Т.К. Breus - Dr.Sc. (Phys.-Math.), Main Research Scientist, Cosmic Investigation RAN (Moscow). Е- mail: breus36@mail.ru V.A. Ozheredov - Ph.D. (Phys.-Math.), Leading Mathematics, Cosmic Investigation RAN (Moscow). Е-mail: ojymail. @mail.ru
The study of peculiarities of antibiotic streptolydigin action on bacterial RNA polymerase
S.D. Zorov - Ph.D. (Biol.), Senior Lecturer, Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia. E-mail: zorov@inbox.ru
Matrix metalloproteinases and their tissue inhibitors in normal and tumors of the kidney
O.I. Kostyleva - Ph.D. (Med.), Senior Research Scientist, Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow E-mail: ok_olga68@mail.ru V.V. Mushtenko - Post-graduate Student, Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow S.D. Bezanova - Post-graduate Student, Pathology Department, N.N. Blokhin Russian Cancer Research Center, Moscow D.S. Mikhaylenko -Ph.D. (Med.), Senior Research Scientist, Institute of Molecular Medicine, Sechenov First Mos-cow State Medical University Senior Researcher Russia, Moscow N.E. Kushlinskii - Dr.Sc. (Med.), Professor, Member-Correspondent of Russian Academy of Sciences, Head of the Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow
The use of vascular endothelial growth factor inhibitors in patients with proliferative diabetic retinopathy

V.Yu. Evgrafov1, G.R. Kudasheva2

1,2 Pirogov Russian National Research Medical University (Moscow, Russia)